Back to Journals » Risk Management and Healthcare Policy » Volume 17

Original Research

Cost-Effectiveness of First-Line Atezolizumab versus Chemotherapy in Non-Small-Cell Lung Cancer Patients Ineligible for Platinum-Containing Regimens

       
Total article views   HTML views PDF downloads Totals
897 Dovepress* 897+ 11 908
Totals 897 11 908
*Since 12 April 2024

View citations on PubMed Central and Google Scholar